Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6430.0000
-32.50
(
-0.50
%)
NSE
Nov 21, 2025
09:56 AM
29.77% Gain from 52W Low
Volume:
17,087
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
08 Aug 2020
6430.00
-0.50%
Divi's Labs (REDUCE): Q1 beat due to lumpiness retain REDUCE on full valuations
Sell:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 2850
Target
BOB Capital Markets Ltd.
Strong execution in Q1 drove a sharp 39% EBITDA beat for Divi's Labs (DIVI).
Divi's Laboratories Ltd. is trading
above its 200 day SMA
of 6217.9
More from Divi's Laboratories Ltd.
Recommended
Market opens lower, TCS forms Rs 18,000 cr JV
Trendlyne Marketwatch |
21 Nov 2025, 09:42AM
Inflation Is near zero. So why Is the RBI not cutting rates?
The Baseline |
20 Nov 2025, 01:04PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022